Skip to content

Opening book details…

Can I read Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients on EtoBox?

Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients by Christian P. Selinger; Gareth C. Parkes; Ash Bassi; Jimmy K. Limdi; Helen Ludlow; Pritash Patel; Melissa Smith; Santosh Saluke; Zandile Ndlovu; Becky George; John Saunders; Mark Adamson; Aileen Fraser; Jenna Robinson; Fiona Donovan; Ioanna Parisi; Jude Tidbury; Lynn Gray; Richard Pollok; Glyn Scott; Tim Raine is a Medicine article available to read on EtoBox.

What is Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients about?

## Background: Patients with ibd are at risk of excess corticosteroids. ## Aims: To assess steroid excess in a large ibd cohort and test associations with quality improvement and prescribing. ## Methods: Steroid exposure was recorded for outpatients attending 19 centres and associated factors analysed. measures taken to avoid excess were assessed. ## Results: Of 2385 patients, 28% received steroids in the preceding 12 months. 14.8% had steroid excess or dependency. steroid use was significantly lower at 'intervention centres' which participated in a quality improvement programme (exposure: 23.8% vs 31.0%, p < .001; excess 11.5% vs 17.1%, p < .001). at intervention centres, steroid use fell from 2015 to 2017 (steroid exposure 30.0%-23.8%, p = .003; steroid excess 13.8%-11.5%, p = .17). steroid excess was judged avoidable in 50.7%. factors independently associated with reduced steroid excess in crohn's disease included maintenance with anti-tnf agents (or 0.61 [95% ci 0.24-0.95]), treatment in a centre with a multi-disciplinary team (or 0.54 [95% ci 0.20-0.86]) and treatment at an intervention centre (or 0.72 [95% ci 0.46-0.97]). treatment with 5-asa in cd was associated with higher

Who reads Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Christian P. Selinger; Gareth C. Parkes; Ash Bassi; Jimmy K. Limdi; Helen Ludlow; Pritash Patel; Melissa Smith; Santosh Saluke; Zandile Ndlovu; Becky George; John Saunders; Mark Adamson; Aileen Fraser; Jenna Robinson; Fiona Donovan; Ioanna Parisi; Jude Tidbury; Lynn Gray; Richard Pollok; Glyn Scott; Tim Raine
Published
2019
Language
EN
Field
Medicine (Health Sciences)

More by Christian P. Selinger; Gareth C. Parkes; Ash Bassi; Jimmy K. Limdi; Helen Ludlow; Pritash Patel; Melissa Smith; Santosh Saluke; Zandile Ndlovu; Becky George; John Saunders; Mark Adamson; Aileen Fraser; Jenna Robinson; Fiona Donovan; Ioanna Parisi; Jude Tidbury; Lynn Gray; Richard Pollok; Glyn Scott; Tim Raine

Browse all works by Christian P. Selinger; Gareth C. Parkes; Ash Bassi; Jimmy K. Limdi; Helen Ludlow; Pritash Patel; Melissa Smith; Santosh Saluke; Zandile Ndlovu; Becky George; John Saunders; Mark Adamson; Aileen Fraser; Jenna Robinson; Fiona Donovan; Ioanna Parisi; Jude Tidbury; Lynn Gray; Richard Pollok; Glyn Scott; Tim Raine